XML 48 R62.htm IDEA: XBRL DOCUMENT v2.4.0.6
Notes and Other Long-term Receivables (Narrative) (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended 1 Months Ended 1 Months Ended 1 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Jan. 31, 2013
Wellstate Credit Agreement [Member]
Dec. 31, 2012
Wellstate Credit Agreement [Member]
Nov. 02, 2012
Wellstate Credit Agreement [Member]
Aug. 31, 2012
Wellstate Credit Agreement [Member]
Mar. 31, 2012
Wellstate Credit Agreement [Member]
Jul. 31, 2012
Merus Labs [Member]
Oct. 31, 2012
AxoGen [Member]
Feb. 28, 2013
Hyperion Purchase and Sale Agreement Receivable [Member]
Mar. 31, 2012
Hyperion Purchase and Sale Agreement Receivable [Member]
Jul. 31, 2012
Initial Loan [Member]
Merus Labs [Member]
Jul. 31, 2012
Additional Loan [Member]
Merus Labs [Member]
Mar. 31, 2012
Senior Secured Note Receivable [Member]
Wellstat Note Receivable [Member]
Dec. 31, 2012
Senior Secured Note Receivable [Member]
Wellstat Note Receivable [Member]
Aug. 31, 2012
Senior Secured Note Receivable [Member]
Wellstat Note Receivable [Member]
Accounts Notes And Loans Receivable [Line Items]                                  
Financing receivable, gross           $ 40,000                 $ 7,500   $ 10,000
Term of receivable (in Duration)                             2 years    
Increase (decrease) in finance receivables                 20,000                
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred                 35,000                
Interest rate of note receivable (in Percent)                         13.50% 14.00%      
Letter of credit extended                 20,000                
Term of Royalty Agreement (in Duration)                   8 years              
First year of contract, AxoGen has the right to call (in Year)                   5              
Last year of contract, AxoGen has the right to call (in Year)                   8              
Total consideration paid to AxoGen for the royalty rights                   20,800              
Initial interim funding for royalty rights                   1,800              
Note receivable, impairment evaluated                               0  
Proceeds received under remedies available for borrower's breach of terms credit agreement       8,100                          
Credit agreement, stated interest rate (in Percent)           5.00% 12.00% 10.00%                  
Amount company has agreed to advance under credit agreement         7,900                        
Repayment of notes receivable 5,000 0 0               1,200            
Notes receivable, net $ 7,504 $ 0                 $ 1,200 $ 2,300